News

CloudLIMS is making its "in the cloud" LIMS free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.

A new study has for the first time uncovered a neurodegenerative disorder in which children experience developmental regression and severe epilepsy.

Wealthy, white California counties--once considered the nation's hotbeds for autism spectrum disorder (ASD)--have seen prevalence flatten or fall in the last two decades, while rates among poor whites and minorities keep ticking up, new CU Boulder research has found.

The FDA has issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test.

To further reduce the risk of transmission of COVID-19 and for the safety of staff, the National Institutes of Health (NIH) is shifting all non-mission-critical laboratory operations to a maintenance phase.

Purdue University engineers have built a device that would allow disease specialists to load an extracellular matrix sample onto a platform and detect its stiffness through sound waves.

A new study has provided the most comprehensive analysis of human genetic diversity to date, after the sequencing of 929 human genomes.

Researchers are using a pioneering imaging technology—called Mango, for its bright color— to develop coronavirus testing kits.

Synthace joins the growing number of companies offering services for free to researchers working to overcome the coronavirus pandemic.

Researchers have developed a diagnostic technique that uses artificial glycan receptors to capture viruses – this holds potential as a test for the novel coronavirus.